Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment

Category Primary study
JournalJ. Dermatol.
Year 2025
This article has no abstract
Epistemonikos ID: ec339eb5d0a9be69dcd1a749b42437c6cc0ec5d4
First added on: Jan 24, 2025